The ELiPSE-1 study: A phase 1, multicenter, open-label study of CNTY-101 in subjects with relapsed or refractory CD19-positive B-cell malignancies

• Published in: Journal of clinical oncology Vol. 41; no. 16_suppl; p. TPS7580
• Main Authors: Rothman, Sarah, Das, Poulomee A, Yee, Stephanie, Ramachandran, Indu, Koumenis, Iphigenia, Cook, Terry A, Yuan, Ying, Trede, Nikolaus S., Mattour, Ahmad Hatem
• Format: Journal Article
• Language: English
• Published: American Society of Clinical Oncology 01.06.2023

TPS7580Background: Century Therapeutics' foundational technology is built on induced pluripotent stem cells, differentiated from allogeneic approaches that utilize non-renewable donor-derived cells. This approach allows production of a clonal cell bank of precisely edited cells that can be expa...